ePRO/eCOA Featured Articles
-
How Blockchain Can Empower Patients And Improve Clinical Trials
8/4/2023
Blockchain is far bigger than cryptocurrency. It's a data encryption technology that can not only strengthen existing clinical systems, but also (and most importantly) empower patients by giving them more control and ownership of their clinical data.
-
Navigate DCTs Thoughtfully To Improve Patient Experience & Increase Trial Accessibility
7/17/2023
People have rapidly adapted to conducting everyday activities through digital applications. Now, decentralized clinical trials are leveraging these technologies to afford patients greater flexibility and accessibility for trial participation.
-
Pitfalls And Possibilities: EHRs To RWD Via EDC
7/5/2023
Consider DIA GCP & QA Community Chair Terry Katz’s perspective on repurposing and analyzing EHR data for clinical research.
-
Key Questions To Ask Clinical Trial Vendors
6/7/2023
Clinical trials are becoming more complex, and the number of contract research organizations and other vendors is growing rapidly. Finding the right vendor begins with asking the right questions.
-
How Sites Are Managing The Rising Costs Of DCTs
5/23/2023
How do DCTs affect site costs? Clinical Leader asked experts to share their thoughts on the rising costs and staffing challenges brought on by the proliferation of DCTs.
-
DCTs And Sites: What Sponsors Need To Know
4/21/2023
Clinical Leader Live held a webinar last August with three decentralized clinical trial (DCT) experts to discuss the history, challenges, costs, and staffing issues surrounding DCTs. Guests Jimmy Bechtel, VP of site engagement for the Society of Clinical Research Sites (SCRS); Brad Hightower, CEO of Hightower Clinical; and Karri Venn, COO, president, and chair of the operating board at Centricity Research, lent their expertise and answered questions from the audience.
-
New EU Directive Marks Cybersecurity Regulatory Paradigm Shift For Bio/Pharma & Medical Devices
2/15/2023
The EU's new Directive 2022/2555 on the Security of Network and Information Systems (“NIS2”) mandates cybersecurity risk management measures and reporting requirements for all segments of our industry, including labs; CROs and CDMOs; and manufacturers of APIs, bio/pharmaceuticals, and medical devices.
-
Boehringer Ingelheim Implements One Medicine Technology Platform
12/8/2022
For years, Boehringer Ingelheim operated with a system comprised of best-of-breed solutions from different vendor companies. After carefully evaluating the technology environment, the company decided to move from best-of-breed solutions to an end-to-end product development platform.
-
Life Sciences RIM: Modernization & Moving Ahead
9/28/2022
Life sciences companies are getting more strategic and ambitious about regulatory information management (RIM). This article shares four key findings from an industry survey and insights for moving ahead in today's world, including a look at advanced technology's role.
-
Evolution Of Electronic Health Record (EHR) Data
5/19/2022
The volume of health data is growing exponentially. Learn about the evolution in the electronic health record (EHR) data landscape in the available interview.